Why Momenta Pharmaceuticals Shares Made a Late-Day Jump Higher

Why Momenta Pharmaceuticals Shares Made a Late-Day Jump Higher·Motley Fool

A patent review board rules that claims on Teva Pharmaceuticals' three-times-weekly version of Copaxone aren't patentable.

Advertisement